The role of NLRP3 in inflammasomes has been studied extensively; it is an important determinant in multiple kidney diseases, including unilateral ureteral occlusion (UUO) [75,76], crystal-induced renal injury [77], nephrocalcinosis-related chronic kidney disease [78] and metabolic syndrome-related kidney disease [79]. Here, NLRP3 is linked to kidney disorder.